2,100 patients enrolled in randomized controlled trial to evaluate a precision-testing pathway for suspected coronary artery disease REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc., a leader in revolutionizing precision heartcare, today announced the completion of patient enrollment in the Prospective Randomized Trial of the Optimal Evaluation […]
Coronary/Structural Heart
Verve Therapeutics to Present Preclinical Data from Gene Editing Programs for the Treatment of Atherosclerotic Cardiovascular Disease at ASGCT
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Verve Therapeutics, a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced the presentation of additional preclinical data from the company’s gene editing programs for the treatment of […]
Alnylam Announces New Advances in ATTR Amyloidosis Program
− Initiates Clinical Study of Biannual Dosing Regimen of Investigational Vutrisiran in hATTR Patients with Polyneuropathy, with Data Expected in 2022 Potentially Supporting sNDA Submission – − Introduces New ATTR Program Aimed at Achieving Annual Dosing Regimen with Highly Potent and Reversible […]
DiA Imaging Analysis Partners with SonoScape Medical Corporation to Deliver Cardiac Ultrasound AI solutions
BE’ER SHEVA, Israel, and SHENZHEN, China , May 10, 2021 /PRNewswire/ — DiA Imaging Analysis Ltd. (DiA), a leading provider of AI-powered ultrasound analysis solutions today announced that it has partnered with SonoScape Medical Corporation (300633.SZ), a leading developer and manufacturer of ultrasound systems. As part of the partnership, SonoScape’s […]
Neovasc Announces First Patient Enrollment in COSIMA Trial
VANCOUVER and MINNEAPOLIS, May 10, 2021 (GLOBE NEWSWIRE) — via NewMediaWire ‒ Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the first patient has been enrolled in the COronary SInus Reducer for the Treatment of Refractory Microvascular Angina (“COSIMA”) trial. The enrollment occurred at University […]
Liquidia Resubmits New Drug Application for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial Hypertension
MORRISVILLE, N.C., May 10, 2021 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) announced today that on May 7, 2021, it resubmitted its New Drug Application (NDA) for LIQ861 for the treatment of pulmonary arterial hypertension (PAH). The U.S. Food and […]
Prevent Heart Disease, Interview With Dr. Rajiv Agarwal of Modern Heart & Vascular Institute
Dr. Rajiv Agarwal (Cardiologist) with Modern Heart & Vascular Institute discusses who should get heart screening and how the latest technology can help. HOUSTON, May 7, 2021 /PRNewswire/ — In April, 2021, Dr. Rajiv Agarwal, board-certified cardiologist at Modern Heart and Vascular Institute, talked about the […]
Daxor Corporation Receives National Institutes of Health (NIH) Funding Notification for Landmark Multi-Center Heart Failure Trial Utilizing the BVA-100® (Blood Volume Analyzer) with the United States Department of Veterans Affairs
NEW YORK, May 06, 2021 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces the initiation of a multi-center clinical trial with two Veterans Affairs Medical Centers to evaluate Blood Volume […]
HeartFlow and MedAxiom Announce Collaboration to Improve Care Delivery for Patients with Coronary Artery Disease
REDWOOD CITY, Calif. & NEPTUNE BEACH, Fla.–(BUSINESS WIRE)–HeartFlow, Inc., a leader in revolutionizing precision heartcare, and MedAxiom, an American College of Cardiology (ACC) company whose mission is to transform cardiovascular care and improve heart health, announced today a collaboration to improve […]
Robocath successfully completes first robotic coronary angioplasties in Belgium
Rouen, France, May 4, 2021 – Robocath, a company that designs, develops and commercializes cardiovascular robotic platforms for the treatment of vascular diseases, today announces the successful completion of first five robotic coronary angioplasties in Belgium. The Percutaneous Coronary Interventions (PCI) were […]